INDV FY 2017 Earnings — Indivior Pharmaceuticals Inc Revenue & Financial Results | Market Cap Arena

INDVIndivior Pharmaceuticals Inc

$4B

FY 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.1B+18.5% YoY

Gross Profit

$1.0B89.3% margin

Operating Income

$423M36.9% margin

Net Income

$61M5.3% margin

EPS (Diluted)

$0.41

Cash Flow

Operating Cash Flow

$310M

Free Cash Flow

$265M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$1.6B

Stockholders' Equity

-$203M

Cash & Equivalents

$863M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$969M	+18.5%
Gross Profit	$1.0B	$858M	+19.5%
Operating Income	$423M	$338M	+25.3%
Net Income	$61M	$32M	+90.1%